Reddit Posts
MDAI - “We are pleased to reach this milestone towards the initial commercialization opportunity for our DeepView AI®-Burn algorithm."
MDAI - announced the submission of an application in the United Kingdom for its predictive software DeepView AI®-Burn to be registered as UK Conformity Assessed (UKCA) for burn wound use in the UK.
MDAI - The DeepView® Wound Imaging System
MDAI nice day to accumulate with FDA pending news
MDAI nice day to accumulate with FDA pending news FDA
MDAI nice opportunity to load up today
MDAI nice week ahead...enjoy the ride
MDAI in the last post I forgot to post CTB situation
MDAI has only 240k float with 50% SI and CTB around 300%
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%.
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%..
NEGG lot of spamming posts by shorters...hope you took your profits. If you are looking for a nice squeeze MDAI is one of the best. The new hype is here.
Did you load up some MDAI in the last days...?
MDAI where could go with the squeeze and the news incoming?
MDAI very tiny float..high SI.. CTB around 300% and news incoming
MDAI accumulation is ending..nice squeeze incoming
Hope you loaded up enough MDAI 2 days ago... squeeze incoming
MDAI very tiny float ..high SI and CTB around 300%
MDAI could pop hard today with tiny float
Penny stocks to watch now? 4 turning heads this week
$MDAI micro float with +$100M in contracts
Mentions
Grabbed a small position in MDAI this morning. Risky but that FDA catalyst later this year is too tempting to ignore.
That 95% accuracy stat vs. 40% for surgeons is insane. If they execute even half of what’s outlined here, MDAI could easily re-rate higher post-FDA. Watching the December catalyst closely.
95% accuracy vs 40% from surgeons? This AI isn’t hype, it’s a weapon. $MDAI looks like a sleeper.
This is a fascinating blend of cutting-edge AI and real-world clinical impact. Spectral AI’s DeepView® showing such high accuracy compared to surgeons is impressive especially with solid backing from the U.S. government and ongoing military trials. The potential here to revolutionize wound assessment and emergency care is huge. If they nail the FDA approval, $MDAI could definitely be a game changer in medtech investing. Definitely keeping an eye on this one!
MDAI has one main product called deepview which is their main AI health diagnostics scanning tool officially approved and deployed in UK hospitals. The next expansion they are aiming for is modifying their deepview system to uncover diabetic foot ulcers and correct treatment for it. In addition a military portable deepview advice for burn wounds is in active development to be released for the us military after fda approval.
Spectral AI $MDAI. They are using AI and machine learning in the healthcare space. They had 95% accuracy and recently filed with the FDA. If they get approved, thank me later, if they don’t, then my advice is don’t invest more than you can lose. Be smart but I think this is a good play
MDAI’s product, DeepView, is a medical device (AI-assisted diagnostic) — not a drug. • These reviews fall under CDRH (Center for Devices and Radiological Health), which operates largely on user fees (MDUFA). • There’s no indication yet that FDA is pausing or slowing reviews of 510(k) or De Novo device submissions.
SANA and MDAI on the move!
Another solid high volume day from $MDAI post on time FDA submission. This confirms the beautiful cup and handle breakout forming since February with a price target of at least $3.20. My personal price target is $5 before I even begin to think about trimming my position, the long term value in this company is there and they have cash runway all the way through 2026 and commercialization. The question that remains is how fast approval is with the FDA already having been in close discussions with the company guiding them since last year…
Well its look like maybe i'll be holding MDAI for another day at least. Two steady green days following their FDA submission.
I’ve been in MDAI since last August and I just averaged up by 5000 shares and 20000 warrants yesterday. We should be in both a fundamental and technical breakout
Nothing new, that form was about the press release today. I would recommend to dive into the warrants, because it’s a very profitable way to leverage the MDAI stock. Strike price of just $2,75, valid until 2028. Redemption price of $18 if the stock is above that for 20-30 days. Probably one of the best investments you can get right now, although you probably need a Schwab bank account or something. Not much brokers do these warrants.
Just got notification today of a Form 8-K being filed with the United States Securities and Exchange Commission. "Common Stock, par value $0.0001 per share MDAI The Nasdaq Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share" what does this mean for shareholders?
Having a great day with MDAI. Nice to see more Green today than the sea of red last week hah.
Thanks for the post! With the excellent news today of FDA submission against most shareholders’ expectations, I was going to need to fit in when I was going to write it up today. So thank you for doing a better job than I would have. I’d like to add one more technical aspect, MDAI has formed a picturesque cup and handle pattern since February, and this regulatory submission spike is the beginnings of the bullish breakout. The typical target for the cup and handle pattern breakout is $3.20 (add the depth to the handle), and I think we can get higher.
I posted about MDAI on this sub months ago telling everyone about this day 😂. I had 1800 shares then and have now accumulated 7000 shares @ 1.54 + warrants. Now hold for 9-12 months for $7-10+ when the inevitable approval comes in. Easy money!
Sunday, 6/29/2025: FDA application already priced in as of 6/27/2025. MDAI stated in earnings call that they anticipate FDA filing in Q2...last day of Q2 is tomorrow, Monday, 6/30/2025. Stock was heavily diluted in past. So far, 2025 has been kinder to shareholders. Six institutional investors closed (smallish) positions in MDAI in Q1 2025 (reported 05/2025). Very mixed signals as to where this is going. MDAI may postpone FDA filing until after 4th July weekend; not a big deal IMO.
I don't have any options but you can buy/sell options on plenty of penny stocks. MDAI warrants can be purchased under MDAIW ticker.
Here are top deep value picks along with my positions. AMPX (3200 @ $2.68) - best batteries in the world and going to turn into a monster soon (IMO). BBAI (2700 @ $4.52) - tons of hype right now but strong potential for major national security, border security, and military contracts. MDAI (7000 @ $1.54 + warrants) - will be applying for FDA approval soon which IMO has a 90% chance of approval on their DeepView burn analysis unit -- then the money rolls in next year. RDZN - Insurance tech company on the verge of profitability in 2025/2026. No position yet but will scale in under $1.40. I think 30-50% upside this year and doubles next year.
This discussion on $MDAI is fascinating! I started using Filter B0unce for email verification while ramping up my cold outreach, and it is proved to be a smart move. The accuracy in email verification and keeping bounce rates down has been essential for maintaining sender reputation. If you want to ensure your cold emails land successfully, I highly recommend giving Filter B0unce a try!
The clinical potential of $MDAI certainly sounds like a breakthrough. On a different note, I have been using D0 You M@il for my cold email campaigns alongside my regular outreach tools, and it is been pretty solid. The ease of setting up automatic SPF, DKIM, and DMARC configurations has saved me so much time. If you need a reliable backbone for your cold emails, D0 You M@il is definitely worth considering!
I totally agree about the impact $MDAI can have on diagnostics! While diving into cold email strategies recently, I discovered Mystr!ka and it is been a game changer. The ability to integrate with GoHighLevel was huge for streamlining my processes. I would suggest you check out Mystr!ka if you are into cold emailing. It offers fantastic warmup options, and you would not be disappointed!
Wow, the FDA approval timeline for $MDAI is a big deal. Speaking of timelines, I have got a great cold email tool that could help while you wait on that. Mystr!ka not only has a top-notch warmup pool but also automatic bounce detection which saves a lot of hassle. If you want to improve your outreach efficiency, I cannot recommend Mystr!ka enough—give it a try!
This $MDAI device sounds promising, especially with those impressive accuracy rates. In the same vein, I have been diving into cold emailing strategies, and Mystr!ka has been a lifesaver. Their A\/B testing feature is unbeatable, and it really helped me refine my messages for better engagement. I seriously recommend giving Mystr!ka a try—it is worth it for anyone looking to boost their emailing efforts.
I am really intrigued by the $MDAI play you have outlined! The efficiency in burn and DFU diagnostics could totally revolutionize healthcare delivery. Speaking of efficiency, I have been using Mystr!ka for cold emailing recently, and it is been fantastic. The user-friendly interface coupled with comprehensive analytics has really improved my outreach results. If you are keen on maximizing your email game, give Mystr!ka a shot, it might elevate your cold emailing experience!
MDAI still moving up, one day, one 🦶step at a time, excellent day to get in.
Great to see bullish price action continuing for $MDAI into the new week. Concrete news on the spinoff or FDA submission by end of month should be a pop
I've been very bullish on MDAI, and their recent earnings report shows even more promise. It's definitely a long play, but everything about this stock is a green flag (imo) This isn't financial advice though. Don't forget I'm just some random 20 year old on the Internet.
I'm incredibly bullish on MDAI, but it's definitely a long term hold imo
MDAI having a great bullish continuation today, I see $3 in the near future returning
I've been doing this for like 6 weeks I'm definitely still in the learning phase. I'll have a look over MDAI though thanks!
Think I could learn a thing or two from you. I guess time will tell I’m going to throw it on the watchlist and see how it plays out. I have been eyeing MDAI for a bit now as well, quite speculative on this one. I can’t be the only one on the fence surely..
I agree on it being hard to tell these days. My feeling with MDAI, based on my research, is that it is lower risk than most AI micro caps, with a lot of upside. We all must weigh the research and decide how much risk we’re willing to take.
That’s why MDAI has $250 million in non-dilutive US government support. They’ve got a huge advantage compared to other pennies that are self-funded, mainly through dilution since it’s difficult to be profitable.
My main area of investing interest is micro/small cap AI, and MDAI is the best play I've found. \-Innovative, effective tech with virtually no competition \-251 million dollars in gov't approved BARDA funds (compare that to their market cap) \-Low float with highly invested leadership \-Proven leadership commitment to avoiding dilution as much as possible \-EXCELLENT burn study results- the importance of this for FDA approval is huge \-Highly likely FDA approval as this is for a non-invasive, probably De Novo device \-Many patents that will remain even if the SMIP spinoff takes place \-Marketing help from BARDA and their funds, which should help jumpstart sales after FDA approval \-Future earnings from Diabetic Foot Ulcers and potentially other areas \-Potential trend stock if/when healthcare AI takes off \-No dilution allowed until September 2025
$MDAI such an interesting company. Was UK London listed prior to NASDAQ IPO and was trading at $6+ at the time of listing. What happened on IPO day was all the UK holders had their shares withheld for months and couldn’t trade. Naked shorts knew this was going to happen and decimated the value. Nothing but good news since from the company and it is now slowly recovering from sub $1. Has potential to really go places. Worth looking into the companies IP and the fact it has huge US government defence money backing.
$MDAI has bargain bin valuation right now at $35 million. Given the rest of their AI medical imaging system pipeline, I could see this company being worth over a billion by 2030. The company is even way undervalued for just their burn indication which will start commercializing in the US in 2026 with $95 million of government support already locked in. They also cannot dilute for another year or so. This stock is hard to see as anything other than a long term no brainer.
$MDAI. AI stocks about to rockeit🍌🚀
Damn, $MDAI is extremely low float. 29.90% borrowing rate. Ready to 🍌🚀
Great point! Definitely check the initial conversion ratio. Most are 1:1, but sometimes you’ll find a different ratio. Such as 2 warrants for 1 share. Then check to see if they have any reverse splits. That will affect the required exchange amount . Like KITTW will take 30 warrants to exercise for one share at the reverse split price. There is a risk they will amend the agreement as well. Which could be beneficial if they adjusted the exercise price to a lower price like MDAI warrants for example. Lastly be aware of the redemption price. If they call the shares back for redemption you will have 30day period to redeem them or you’ll miss the boat altogether.
Spectral AI (ticker:MDAI) might be one to take a small position in. Unique product patented IP.
might as well get some $MDAI then
RKLB, MDAI, BKSY, KULR and ELPT have done well. Waiting on IOVA, AMPH, HALO, BIOX, WYY, and a few others.
Currently holding: CTM, IBRX, HAO, MDAI, WKSP. What am I missing, for swing trades?[](https://www.reddit.com/user//)
OPTT (later in 2025), CTM, WKSP, MDAI, WIMI
I started buying penny stocks this year. Mostly very small amounts because of the risk. But several of them have exploded -- ELTP, RKLB, KULR, MDAI. I reject most of the recommendations, but I have about a dozen now. One effect is that it makes it easier to be patient with the more slowly growing large caps.
Personally I’m only invested in two stocks, one of them being $MDAI. They are a company that have developed a machine learning algorithm to predict on day one if a burn wound will heal or require surgery ($4B market) with greater than 90% accuracy. Their platform is versatile and is also going to be used for diabetic foot ulcers ($11B market) after they get their burn system to market. They have a $150M active contract with the US government to develop and distribute their product, all that’s left is FDA approval. Their US burn study results are slated for later this month, and their FDA submission is expected to be H1 ‘25. I’m the most confident in FDA approval I could possibly be, they even already have UKCA approval and are going to have their first sales in the UK any day now. My thesis has me in for the long term, half my position are warrants that expire in 2028. They also have a few analysts covering them, the lowest of which have a $4 price target, the highest is $10. $MDAI has been getting a lot more volume lately, things seem to be heating up and hopefully the market will finally acknowledge Spectral AI with a reasonable valuation.
I bought KULR, MDAI and ELTP. I sold KULR at +200% after the BTC news (I have no idea what will happen now and I don't like gambling). I'm very bullish on MDAI ane ELTP. Solid companies, good CEOs, good track record, clear catalysts.
I look at various Reddit forums. When I look at a stock, I also look at comparable companies shown on the trading platforms. Sometimes they are better. I am less concerned about a good product story or future estimates. and more concerned with recent performance. I generally choose stocks with growing revenue. I avoid companies which are losing money and do not look able to turn a profit in a year. That restricts the pool a bit, but there are still lots of companies to choose from. I have done extraordinarily well this year: ELTP +1700%, KULR +290%, RKLB +290%, MDAI +98%, BKSY +30%, WYY +24%
$GFAI 🚀 BREAKING OUT, following $MDAI, $SOUN and $BBAI move
I appreciate the nice MDAI overview, I’d just like to add a small correction. The BARDA contracts are not particularly for the DeepView Snapshot M device, that device is instead being funded mostly separately through MTEC (>$7M so far in non-dilutive funding) since it’s first going to have military applications. [https://finance.yahoo.com/news/spectral-ai-awarded-additional-funding-120000227.html](https://finance.yahoo.com/news/spectral-ai-awarded-additional-funding-120000227.html).
I can see why you'd say that and I do not blame you. Yes it is true that this is my first stock play I've felt confident enough in to post about. Not unrelated but I was motivated to post about it because of the complete lack of discussion about this stock on Reddit across the board. I've used Reddit for 5 years for advice on stock plays and have gained a lot of value and knowledge using it. I figured its finally my turn to give back and start discussions on a stock and company that would otherwise go unnoticed. The commentators you are seeing on my old posts that are new or otherwise unused Reddit accounts are probably people from StockTwits who wanted to see my DD post. There's a thriving MDAI community over there and I wanted to share some of the information to Reddit which I use first and foremost for stock plays. Thanks for thinking it's a wonderful play! I'm blushing
My DD is looking at OP’s profile and seeing that they have consistently only been posting and commenting about this seemingly wonderful play. Then you look back further and the accounts that are commenting on OPs first MDAI post have only commented a few times, say roughly the same thing to OP, and their first comment is as old as their account. TLDR: Fake, stay away. Not financial advice
I think it should hit $100 (no ulterior motives). Serious note: Warrants repriced to $2.75 exercise price so it seems like they are hopeful it’ll at least hit that and they are spinning off a part of the company so those who have MDAI shares will get ‘free’ shares of that. Possible that might effect MDAI negatively though. To conclude….I don’t know.
I buy small biotech companies, but only after they are generating revenue and are growing. I do not feel able to judge the technical merits of the products or how realistic the projections are. Paying customers are a good substitute, in some ways better. I am holding small amounts of MDAI, CERS, BIOX, IOVA, HALO, and EVGN.
MDAI continuing to crush it (more importantly for me the warrants are).
PLTR, IONQ warrants ($6k worth at $4/warrant netted $30k), QBTS warrants, MDAI warrants, RKLB, LUNR warrants, SMCI (went $40k in when it went to $23/share). I’ve taken $60k in profits and riding the rest now.
MDAI repricing warrants to exercise price of $2.75/share.
MDAI up 50% AH on about 4 million volume which is astronomical for it. No news that I’ve seen yet.
I like MDAI. It seems to cycle from $1.06 to $1.70 frequently.
Unfortunately we don’t track ELTP yet but here’s MDAI: Spectral AI, Inc. (MDAI) is currently trading at $1.18 with a market cap of approximately $21 million, showing low volume compared to its 65-day average. The stock’s RSI indicates it’s oversold, suggesting potential for a rebound, but the MACD histogram remains negative, pointing to continued bearish momentum. Recent funding and strategic developments, including a $250 million non-dilutive funding and potential short squeeze due to naked short selling concerns, add a positive tilt to sentiment. However, technical indicators like the SMA and EMA are trending below recent prices, indicating resistance ahead. Given the mixed sentiment and technical setup, a cautious long position could be considered with an entry around $1.15, targeting $1.25 as the first price target and $1.35 as the second, while setting a stop loss at $1.10. Confidence in reaching the first target is moderate due to potential short squeeze catalysts, but the second target carries lower confidence given broader market uncertainties. Investors should closely monitor upcoming study results and spinoff developments, which could significantly impact MDAI’s performance.
ELTP and MDAI (Spectral AI) please
MDAI doing a spinoff apparently. Not sure if that’s good or bad.
A limit order just means that they have a buy order set to execute if the price reaches $1.11, buying at prices up to $1.11. $MDAI does not have options trading yet because it is too small of a company.
Yes this selling the past 3 months has been very suspicious when considering the naked short investigation requests the company has requested of NASDAQ. Last I've heard, the investigation has been taken up with FINRA and now no info can be leaked until the investigation is over, not even to the company's management. MDAI already has significant short interest, so if their >40% of outstanding shares naked short claims are true, there could be substantial covering. Of course this was not my investment thesis going into this, but a development that has occurred alongside improvement and focus on the company's solid fundamentals.
Sofi, I’m up about 10% so right about $7. MDAI, I’m in the warrants when they were going with a different company as a SPAC so around $.75 😮 ORGN $1.55.
SOFI, MDAI (only because I’m down so much. Just hoping I can get a little more back at some point), and small bit of ORGN (bought back in recently as they appeared to be turning things around a bit but had possible bearish news today depending on perspective).
I mean if you want to make money in with a reasonable fundamental thesis, check out $MDAI. They are pre-FDA approval but post UKCA approval as a Class I medical device. Imo, very likely to be approved next year with commercialization news in the UK to hold you over to then.
Personally, I would not invest in this company. From what I can tell, they are touting the potential benefits of AI without having a tangible product with proof of value. This is not a good way to get broad commercialization and drive demand for your product. I would like to see reasonable revenue projections for their software service that would not only justify their current $40 million market cap, but allow for substantial future growth. Otherwise, I am just not convinced about the power of a jack-of-all-trades AI platform to 'revolutionize' all aspects of healthcare other than treatment. AI is at its most useful when trained very specifically to learn a single task. They've touched on how AI can be utilized to analyze medical device data to provide an accurate diagnosis which is one such specific use case. However, they do not seem to make this a focus for their company, and for that reason I do not see their value proposition. If you are still confident in AI's use in healthcare, I would look to $MDAI as an example of a focused company that is trying to solve a specific problem effectively with machine learning. If that sounds appealing, I have more information on my profile or lets discuss.
Yeah the warrant exercise price is quite up there compared to current share prices, but they are also expiring in 4 years. By Sept 2028, MDAI is anticipating to have significantly commercialized both their burn and DFU products in multiple countries. I believe a successful commercialization of both burn and DFUs would make the company worth well more than $11.50 a share. Especially if they have more applications on the horizon at that point as well, which they have suggested adapting their work towards (wound bed prep, amputations, therapy, critical limb ischemia). Here is an image from their investor presentation I was not able to put on the main post. https://preview.redd.it/0h992gb8igmd1.png?width=1722&format=png&auto=webp&s=3913fe3c0cdb2837f5073f66f1cf7db7fc040bbf
Not sure if this makes MDAI more attractive to you but currently only about $400k of commercial revenue is expected for FY24 from their first few contracts in the UK. The $28 million in revenue guided for 2024 is vastly just R&D grant money from BARDA Project BioShielf and a smaller \~$4 million US military contract to miniaturize their device for the battlefield medics. Yes, if they are not able to commercialize DeepView in the US for burn, they'll be in a pretty dire financial situation. However, the US government seems pretty invested in the success of this technology from multiple angles.
I appreciate you bringing up another company in the space. Healwell AI appears to be a holding company that has bought out a plethora of AI medical diagnostics and logistics companies. Some in production and being actively used, others awaiting approval and commercialization just like MDAI. Healwell also has a $228 million dollar market cap, so much higher expectations of value are baked into the current price. The way I see the difference between these two investments is do you want to bet on the more general success of AI in healthcare by diluting your share of any single application and reducing your risk? If so, Healwell could be a buy to you. But if you believe in this more specific application, you could get much better returns in addition to keeping track of your investment thesis better with investing in MDAI. In my opinion, and research analysts’, MDAI’s market cap at $26 million leaves a lot of growth on the table if they have a commercially successful product and you’d be capturing all that upside by investing in them. But yeah who would need their diagnostic technology, it’s so rare to get an MRI no? Well MDAI’s DeepView AI system uses almost a normal camera (the spectrum is expanded a bit outside of visual frequencies to be able to consider more information than a physician’s naked eye) to take a quick picture and give an actionable diagnosis for the patient in less than 30 seconds of processing. This advice on what parts of the wound are healing vs nonhealing is especially helpful to the medical community in the face of declining burn specialist training ([the demand](https://journalofethics.ama-assn.org/article/problems-and-costs-could-be-addressed-improved-burn-and-wound-care-training-health-professions/2018-06)) MRI multi-hour imaging is a completely different beast for internal organ imaging, it shouldn’t be compared. Burns and diabetic foot ulcers are a large but specific market which is perfect for an AI application to make ground in. Spectral AI has gotten a ton of money from the US government yes, I’m not sure why you are trying to spin that as a negative. The company has the US government’s support and MDAI has met or beat all of their imposed timelines such as their earlier than expected full enrollment in a US burn clinical trial for FDA approval ([source](https://investors.spectral-ai.com/news-releases/news-release-details/spectral-ai-completes-burn-center-enrollment-us-burn-pivotal)). With the UK government having approved their device and demand being apparent already for burns, I don’t see the commercial flop being all that likely. All that said, do your own research.
Why should I prefer MDAI over it's competitor [Healwell.ai](http://Healwell.ai) (H90F)? Healwell seems not to have burned some houndred millions of gouverment money (here named BARDA warrants) instead their shares were down to 9 cents. Restructuring. Now they are back at 1.30$ and the Healwell AI model is already "in production", meaning therapists are using it to optimize therapies. MDAI is passing FDA approvements right now, but they burned 250 million US$ and more 150 are in sight... lets say they get their product FDA approved. The Healwell product is "something with AI" but it doesnt have this "must have" factor, and it is a many trick pony. The product of MDAI is a one trick pony, it can distinguish between healing and non healing wounds... so very specialized like MRT devices. During my entire lifetime I had been once in a MRT :-(
Why should I prefer MDAI over it's competitor [Healwell.ai](http://Healwell.ai) (H90F)? Healwell seems not to have burned some houndred millions of gouverment money (here named BARDA warrants) instead their shares were down to 9 cents. Restructuring. Now they are back at 1.30$ and the Healwell AI model is already "in production", meaning therapists are using it to optimize therapies. MDAI is passing FDA approvements right now, but they burned 250 million US$ and more 150 are in sight... Lets say I am not a pro investor, but I have some market knowledge in the pharma industry. The drug you get approved today may skyrocket the company and later fall on your feet like Contergane 50 years ago... Of course I believe in AI based image recognition - which is currently a domain of humans but AI is gaining more and more market share there. But till today it is not revolution, there was a similar thing promosed for skin cancer. As I went to my doctor recently for a skin cancer screening... he did this with his eyes. And when my wife was pregnant we went to a universities nursery department (because of a high risk pregnancy) the analysis was done manually... When it is about medicine I believe more in robots. My dad had a robot assisted surgery with his hip junction some 40 years ago but till today robots are rarely used except in cutting bones for prothetic replacement.
Spectral AI - MDAI. Good AI medical device company about to go into full production as well as get FDA approval (early 2025). Price has been pushed down by naked shorts so it is a great time to buy on the cheap. Analysts have it projected on average to around 6. (currently 1.5) Also is becoming a viable short squeeze candidate since shorts are now over 10%. (this micro-cap keeps getting more and more interest and the shorts have to do more and more to create downward pressure)
For sure, high risk high reward Appreciate the heads up on MDAI
Hey man with that time frame you’re kinda gambling cough cough I mean trading. But that being said check out MDAI penny stock I’ve fallen in love with recently😂 not financial advice and would not recommend putting the entire 20k on it obv😂
Check out MDAI, looks like a promising stock to me trading at $1.60 currently
Just remember that the possibility that it won't is as heavy as the possibility it will provided you enter the chat. I called GME at 10 bucks 3 weeks before the latest run to 80 PM. I called Nvax at 3.85 it doubled I sold then proceeded to climb over 20 in less than 3 months. I called VYGR and MDAI. It's easy to spot discounts when you know what conditions are favorable. All of this is proven with date stamps on my callouts and ideas. If you ever wanna collaborate or share data hmu learning is the new meth
MDAI, tech is promising, trials are small but they expect FDA approval soon. The use multispecrtal imaging and machine learning to predict burn recovery outcomes. I'm a big believer in AI in healthcare generally. It's one of the few places the dispassionate judgement of AI will be more effective than messy human judgements.